Previous studies reported differential expression of S100A9 in non-small cell lung cancer [11], breast cancer [12,13], gastric cancer [14], and colorectal cancer [15] by immunohistochemistry, consistent with the results of the present immunohistochemistry and microdissection-based mRNA analyses of OS and normal bone tissues. This evidence concerns the gene S100A9 and colorectal cancer.